Japan Cataract Surgery Devices Market Trends 2025–2033
Buy NowJapan Cataract Surgery Devices Market Size
Japan Cataract Surgery Devices Market is expected to reach US$ 540.64 million by 2033 from US$ 410.75 million in 2024, with a CAGR of 3.10% from 2025 to 2033. An aging population, an increase in the prevalence of cataracts, technological developments in surgical equipment, rising healthcare costs, government assistance for senior care, better surgical results, and a growing desire for minimally invasive procedures are the main factors propelling the Japanese market for cataract surgery devices.
Japan Cataract Surgery Devices Market Report by Product Type (Intraocular Lens, Phacoemulsification Systems, Femtosecond Laser, Ophthalmic Viscoelastic Devices and Other Consumables), End Use (Hospitals, Ophthalmic Clinics, Research Institutes), Region and Company Analysis 2025-2033.
Japan Cataract Surgery Devices Industry Overview
A clouded natural lens is removed and replaced with an artificial intraocular lens (IOL) during cataract surgery procedures, which are performed using specialized medical tools and equipment known as cataract surgery devices. Phacoemulsification machines, which break up cataracts using ultrasonic energy; femtosecond lasers, which make precise incisions; ophthalmic viscoelastic devices (OVDs), which preserve the structure of the eye during surgery; and other surgical tools and IOLs are important technologies. These tools improve visual results, shorten recuperation times, and increase surgical accuracy. Cataract surgery is becoming safer, quicker, and more effective because to technological developments, which also greatly improve patients' quality of life everywhere.
The market for cataract surgical devices in Japan is expanding steadily, mostly due to the nation's increasingly aging population, which raises the prevalence of cataracts considerably. The demand for contemporary technologies has been fueled by technological breakthroughs that have increased surgical precision and patient outcomes, such as femtosecond laser-assisted cataract surgery (FLACS), high-end intraocular lenses (IOLs), and upgraded imaging systems. Advanced surgical equipment is used in Japan because of its well-established healthcare system, strong emphasis on innovation, and highly qualified workforce. The industry is also expanding as a result of government programs supporting cutting-edge medical technology and rising public knowledge of eye health and available treatments.
Growth Drivers for the Japan Cataract Surgery Devices Market
Aging Population
One of the main factors propelling Japan's market for cataract surgery equipment is the country's aging population. In 2023, more than 10% of Japan's population was 80 years of age or older, making it one of the oldest countries in the world, according to the World Economic Forum's September 2023 report. In addition, 36.23 million Japanese citizens, or roughly one in three, were over 65 in that year. The need for cataract procedures has increased dramatically as a result of this demographic transition, as cataracts primarily afflict older persons. The growing elderly population requires advanced surgical devices such as femtosecond lasers, phacoemulsification machines, and premium intraocular lenses (IOLs) to improve vision and quality of life. The aging population's constant need is fueling innovation and growth in Japan's market for cataract surgery equipment.
Technological Advancements
The market for cataract surgery devices in Japan is expanding due in large part to technological improvements. By providing precise, bladeless incisions, improving surgical precision, and shortening recuperation times, innovations such as femtosecond laser-assisted cataract surgery (FLACS) have completely changed processes. Furthermore, the creation of high-end intraocular lenses (IOLs), like multifocal and extended depth of focus lenses, has enhanced visual results and met the various refractive needs of patients. The precision and customization of treatment plans are further enhanced by the use of artificial intelligence (AI) and machine learning into surgical and diagnostic instruments. The market is expanding as a result of these technological advancements and Japan's strong healthcare system, which help to address the country's growing demand for cataract procedures.
Healthcare Infrastructure
The market for cataract surgical instruments in Japan is expanding at a substantial rate owing to its sophisticated healthcare system. Modern surgical technologies like femtosecond lasers, phacoemulsification systems, and high-end intraocular lenses (IOLs) are available at the country's reputable medical institutions, which include hospitals and specialty ophthalmology clinics. These facilities employ highly qualified ophthalmic surgeons who are knowledgeable about the most recent surgical methods, guaranteeing top-notch treatment and the best possible results for patients. Furthermore, the Pharmaceuticals and Medical Devices Agency (PMDA) oversees Japan's strong regulatory environment, which guarantees the effectiveness and safety of medical devices, building confidence and promoting the use of cutting-edge cataract surgery technology. Japan is positioned as a leader in cataract surgery, satisfying the growing demand brought on by its aging population because to the combination of technological innovation and a robust healthcare system.
Challenges in the Japan Cataract Surgery Devices Market
High Cost of Advanced Devices
One major obstacle facing the Japanese market is the high cost of sophisticated cataract surgery equipment. Due to their high cost, technologies like femtosecond lasers, high-end intraocular lenses (IOLs), and sophisticated phacoemulsification equipment are less affordable for smaller clinics and hospitals. Furthermore, patients are financially burdened because these expenses are frequently not entirely covered by Japan's national health insurance, particularly for premium IOLs. This hinders the broad adoption of state-of-the-art technologies, resulting in inequalities in the quality of care and limiting the market's overall growth for cataract surgical devices, especially outside of major cities.
Regulatory Hurdles
The market for cataract surgery devices in Japan is severely hampered by regulatory barriers. To guarantee the security and effectiveness of medical equipment, the Pharmaceuticals and Medical equipment Agency (PMDA) implements stringent and intricate approval procedures. Although necessary for patient safety, these rules may impede market agility and competition by delaying the adoption of cutting-edge technologies. Manufacturers must spend more time and money bringing innovative technologies to market due to lengthy clinical trials, copious documentation, and regulatory requirements. Navigating Japan's distinct regulatory environment presents extra challenges for foreign businesses, which could impede the nation's uptake of cutting-edge cataract surgery techniques.
Japan Cataract Surgery Devices Market Segmentation:
Product Type
- Intraocular Lens
- Phacoemulsification Systems
- Femtosecond Laser
- Ophthalmic Viscoelastic Devices and Other Consumables
End Use
- Hospitals
- Ophthalmic Clinics
- Research Institutes
Region
- East
- South
- North
- West
All companies have been covered from 4 viewpoints:
- Company Overview
- Key Persons
- Recent Development & Strategies
- Sales Analysis
Key Players Analysis
- Alcon, Inc.
- Johnson & Johnson
- Carl Zeiss Meditec AG
- Bausch & Lomb, Inc.
- Topcon Corp
- STAAR Surgical Co
- Glaukos Corp
- Abbott Laboratories
Report Details:
Report Features | Details |
Base Year |
2024 |
Historical Period |
2021 - 2024 |
Forecast Period |
2025 - 2033 |
Market |
US$ Billion |
Segment Covered |
Product Type, End User and Region |
Region Covered |
|
Companies Covered |
|
Customization Scope |
20% Free Customization |
Post-Sale Analyst Support |
1 Year (52 Weeks) |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
Customization Services available
- Analysis of Market Size and Its Segments
- More Company Profiles (Upto 10 without any additional cost):
- Additional Countries (Other than mentioned Countries):
- Region/Country Specific Reports:
- Market Entry Strategy:
- Region-Specific Market Dynamics:
- Regional Market Share Analysis:
- Trade Analysis:
- Production Insights:
- Others Customized Requests:
For more information contact our analysts.
Need More Assistance?
- Talk to our analysts to get more precious information on the current market trends.
- Include more countries and segments and customize the report based on the final requirement.
- Get a competitive advantage in your industry by knowing the report findings and making a positive impact on your revenues and operations.
- Our analysts are always ready to provide more help and pertinent information if you need any additional assistance.
1. Introduction
2. Research & Methodology
2.1 Data Source
2.1.1 Primary Sources
2.1.2 Secondary Sources
2.2 Research Approach
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.3 Forecast Projection Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenges
5. Japan Cataract Surgery Devices Market
5.1 Historical Market Trends
5.2 Market Forecast
6. Market Share Analysis
6.1 By Product Type
6.2 By End Use
6.3 By Region
7. Product Type
7.1 Intraocular Lens
7.2 Phacoemulsification Systems
7.3 Femtosecond Laser
7.4 Ophthalmic Viscoelastic Devices and Other Consumables
8. End Use
8.1 Hospitals
8.2 Ophthalmic Clinics
8.3 Research Institutes
9. Region
9.1 East
9.2 South
9.3 North
9.4 West
10. Porter’s Five Forces Analysis
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. SWOT Analysis
11.1 Strength
11.2 Weakness
11.3 Opportunity
11.4 Threat
12. Key Players Analysis
12.1 Alcon, Inc.
12.1.1 Overview
12.1.2 Key Persons
12.1.3 Recent Development & Strategies
12.1.4 Revenue Analysis
12.2 Johnson & Johnson
12.2.1 Overview
12.2.2 Key Persons
12.2.3 Recent Development & Strategies
12.2.4 Revenue Analysis
12.3 Carl Zeiss Meditec AG
12.3.1 Overview
12.3.2 Key Persons
12.3.3 Recent Development & Strategies
12.3.4 Revenue Analysis
12.4 Bausch & Lomb, Inc.
12.4.1 Overview
12.4.2 Key Persons
12.4.3 Recent Development & Strategies
12.4.4 Revenue Analysis
12.5 Topcon Corp
12.5.1 Overview
12.5.2 Key Persons
12.5.3 Recent Development & Strategies
12.5.4 Revenue Analysis
12.6 STAAR Surgical Co
12.6.1 Overview
12.6.2 Key Persons
12.6.3 Recent Development & Strategies
12.6.4 Revenue Analysis
12.7 Glaukos Corp
12.7.1 Overview
12.7.2 Key Persons
12.7.3 Recent Development & Strategies
12.7.4 Revenue Analysis
12.8 Abbott Laboratories
12.8.1 Overview
12.8.2 Key Persons
12.8.3 Recent Development & Strategies
12.8.4 Revenue Analysis
Reach out to us
Call us on
USA: +1-478-202-3244
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com